Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ATP2B1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PKN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM114A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FGFR1OP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF506 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
MDFIC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NACA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
NFYB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDK17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GOLT1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAHD2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPTC7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UHRF1BP1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PREPL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NADK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SAMD9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR6758 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on